Search Results

CNNC Atom High-Tech Sodium Iodide Capsules Supplied Directly to Macao for the First Time

Recently, sodium iodide [¹³¹I] capsules independently developed and produced by Atom High-Tech Co., Ltd., a subsidiary of China Isotope & Radiation Corporation under CNNC, successfully arrived at clinical frontlines in Macao, achieving the first stable supply of domestically produced sodium iodide [¹³¹I] capsules to Macao and completely filling the previous gap in Macao's lack of this clinical diagnostic and therapeutic service. It is understood that sodium iodide [¹³¹I] capsules are core radiopharmaceuticals widely used clinically for the diagnosis and treatment of thyroid diseases. Previously, Atom High-Tech had successfully achieved routine supply of short-half-life radiopharmaceuticals to Macao; the successful launch of this new product will strongly support Macao medical institutions in carrying out systematic radionuclide therapy and effectively reduce the burden of cross-border medical treatment on local patients.

2026-11-02

Phase II of China Spallation Neutron Source in Dongguan expected to be completed by 2029

On August 26, a media delegation from the Guangdong-Hong Kong-Macao Greater Bay Area visited the China Spallation Neutron Source (CSNS) in Dongguan to learn about the operation of this major scientific facility and the progress of its Phase II project. The CSNS is China's first and the world's fourth pulsed spallation neutron source, often referred to as a "super microscope" for exploring the microscopic world. Since its opening in 2018, the facility has been operating in areas including basic research, research addressing major national needs, industrial innovation, and the integration of Hong Kong and Macao in science and technology innovation, and has become one of the key scientific research platforms in the Greater Bay Area. Tong Xin, Deputy Director of the Spallation Neutron Source Science Center, stated that the Phase II project of the CSNS is currently under construction, with a construction period from January 2024 to October 2029...

2026-08-26

CGN Guangdong Taipingling Nuclear Power Project Unit 2 Officially Commences Commercial Operation

On August 3, CGN Guangdong Taipingling Nuclear Power Project Unit 2 officially commenced commercial operation, marking the full completion of the Phase I project of the first Hualong One self-developed third-generation nuclear power project in the Guangdong-Hong Kong-Macao Greater Bay Area. Located in Huidong County, Huizhou City, Guangdong Province, the Taipingling Nuclear Power Project's Phase I includes Units 1 and 2, which received national approval on April 8, 2019. Among them, Unit 1 of the project commenced commercial operation in April this year. The construction team fully leveraged experience from previous Hualong One projects, successively completing a series of major engineering milestones including nuclear island main structure construction, equipment installation and commissioning, nuclear fuel loading, first criticality of the reactor, and grid connection for power generation, with steady improvements in project construction quality, safety levels, and construction efficiency...

2026-08-03

Science and Technology Professionals from Hong Kong and Macao Visit Yangjiang Nuclear Power Plant to Deepen Collaborative Public Education on Nuclear Safety in the Greater Bay Area

Recently, the themed event "Beautiful China, Volunteering with Me—Nuclear Safety Safeguards a Better Life," hosted by the China Association for the Promotion of Nuclear Safety and Environmental Culture and organized by Yangjiang Nuclear Power Co

2026-07-27